Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al.
Why do many MM patients relapse after being treated with targeted therapy?
How can standard risk multiple myeloma (MM) patients be cured?
Current research on diffuse large B-cell lymphoma (DLBCL)
Immunotherapy for the treatment of multiple myeloma